Latest news
Loading news…
Therachon is a global biotechnology company focused on developing medicines for rare, genetic diseases
Therachon was acquired by Pfizer in 2019 for $340M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Basel, Basel-Stadt, Switzerland
Acquisitions by Therachon
Loading columns…
0 of 0Show
Page 1 / 1
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Therachon
Loading news…
FAQs about Therachon
People who checked this page also checked these
Sectors Therachon invests & acquires in
Browse the full Acquirezy directory.